Advertisement
Canada markets close in 4 hours
  • S&P/TSX

    22,368.43
    -7.40 (-0.03%)
     
  • S&P 500

    5,215.62
    +1.54 (+0.03%)
     
  • DOW

    39,447.26
    +59.50 (+0.15%)
     
  • CAD/USD

    0.7320
    +0.0009 (+0.12%)
     
  • CRUDE OIL

    78.89
    -0.37 (-0.47%)
     
  • Bitcoin CAD

    83,252.11
    -1,650.52 (-1.94%)
     
  • CMC Crypto 200

    1,262.56
    -95.45 (-7.02%)
     
  • GOLD FUTURES

    2,371.20
    +30.90 (+1.32%)
     
  • RUSSELL 2000

    2,057.55
    -16.08 (-0.78%)
     
  • 10-Yr Bond

    4.4980
    +0.0490 (+1.10%)
     
  • NASDAQ

    16,317.97
    -28.29 (-0.17%)
     
  • VOLATILITY

    12.79
    +0.10 (+0.79%)
     
  • FTSE

    8,433.76
    +52.41 (+0.63%)
     
  • NIKKEI 225

    38,229.11
    +155.13 (+0.41%)
     
  • CAD/EUR

    0.6791
    +0.0013 (+0.19%)
     

Andlauer Healthcare Group's (TSE:AND) investors will be pleased with their 25% return over the last year

If you want to compound wealth in the stock market, you can do so by buying an index fund. But if you pick the right individual stocks, you could make more than that. For example, the Andlauer Healthcare Group Inc. (TSE:AND) share price is up 25% in the last 1 year, clearly besting the market return of around 4.3% (not including dividends). If it can keep that out-performance up over the long term, investors will do very well! Note that businesses generally develop over the long term, so the returns over the last year might not reflect a long term trend.

Now it's worth having a look at the company's fundamentals too, because that will help us determine if the long term shareholder return has matched the performance of the underlying business.

See our latest analysis for Andlauer Healthcare Group

There is no denying that markets are sometimes efficient, but prices do not always reflect underlying business performance. One imperfect but simple way to consider how the market perception of a company has shifted is to compare the change in the earnings per share (EPS) with the share price movement.

ADVERTISEMENT

During the last year Andlauer Healthcare Group grew its earnings per share (EPS) by 117%. It's fair to say that the share price gain of 25% did not keep pace with the EPS growth. Therefore, it seems the market isn't as excited about Andlauer Healthcare Group as it was before. This could be an opportunity.

You can see how EPS has changed over time in the image below (click on the chart to see the exact values).

earnings-per-share-growth
earnings-per-share-growth

We like that insiders have been buying shares in the last twelve months. Having said that, most people consider earnings and revenue growth trends to be a more meaningful guide to the business. It might be well worthwhile taking a look at our free report on Andlauer Healthcare Group's earnings, revenue and cash flow.

A Different Perspective

Andlauer Healthcare Group shareholders should be happy with the total gain of 25% over the last twelve months, including dividends. Unfortunately the share price is down 4.4% over the last quarter. Shorter term share price moves often don't signify much about the business itself. While it is well worth considering the different impacts that market conditions can have on the share price, there are other factors that are even more important. To that end, you should be aware of the 3 warning signs we've spotted with Andlauer Healthcare Group .

Andlauer Healthcare Group is not the only stock that insiders are buying. For those who like to find winning investments this free list of growing companies with recent insider purchasing, could be just the ticket.

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on CA exchanges.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.